Clinical Trial

Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser

Recruiting
View on ClinicalTrials.gov →
Summary
ariessence is intended to be used as a viscous, leave-on solution designed for topical application to the face. It is intended to be used following non-medical cosmetic procedures, performed by licensed healthcare professionals to enhance comfort and maintain skin hydration. This study is designed to be a multi-center, post-market cosmetic evaluation of ariessence applied to the full face after an ablative laser procedure to evaluate improvements in procedure tolerability and improvements in the appearance of the skin, compared to an emollient control.
Trial Details
NCT Number NCT07718347
Lead Sponsor Lynch Regenerative Medicine
Conditions Immediate Post-Treatment Care, Aging Mid-Face, Aging
Enrollment 21 participants
Start Date 2026-04-16
Primary Completion 2026-11 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-21